本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Inogen Inc

8.67
+0.08000.93%
成交量:9.48万
成交额:81.54万
市值:2.34亿
市盈率:-8.26
高:8.71
开:8.62
低:8.38
收:8.59
52周最高:12.91
52周最低:5.70
股本:2,704.04万
流通股本:2,395.93万
量比:0.60
换手率:0.40%
股息:- -
股息率:- -
每股收益(TTM):-1.0493
每股收益(LYR):-1.5172
净资产收益率:-13.46%
总资产收益率:-6.24%
市净率:1.18
市盈率(LYR):-5.71

数据加载中...

公司资料

公司名字:
Inogen Inc
交易所:
NASDAQ
成立时间:
2001
员工人数:
766
公司地址:
859 Ward Drive,Goleta,California,United States
邮编:
93111
电话:
传真:
- -
简介:
Inogen, Inc.于2001年11月27日在特拉华州成立,是一家医药技术公司,主要开发、生产和销售新型可携带医用制氧机给长期补充氧气疗法的病人,这些病人患有慢性阻塞性肺病(COPD)和其慢性呼吸道疾病。拥有所有权的Inogen一号系统的设计目的是解决传统氧气疗法模型(送氧模型)的影响患者生活质量和缺陷的问题。

董事

名称
职位
Kevin R. M. Smith
Chief Executive Officer, President and Director
Elizabeth A. Mora
Chairperson of the Board
Glenn S. Boehnlein
Independent Director
Heather Rider
Independent Director
Kevin M. King
Independent Director
Mary Katherine Ladone
Independent Director
Mira Kirti Sahney
Director

股东

名称
职位
Kevin R. M. Smith
Chief Executive Officer, President and Director
Gregoire Ramade
Executive Vice President and Chief Commercial Officer
Jennifer Yi Boyer
Executive Vice President, Enterprise Enablement and Chief Human Resources Officer
Kevin P. Smith
Executive Vice President, Business Development, General Counsel and Secretary
Mary Wright
Chief Accounting Officer
Michael Bourque
Principal Accounting Officer and Principal Financial Officer